Corticosteroids + Ruxolitinib for graft vs host disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 22 Dec 2025: Trial registered, NCT07297914
  2. 7 Jan 2026: Trial started, NCT07297914

The trials

NCT07297914: Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL

State
Under way
Phase
Phase 2 and Phase 3
People
1,000 planned
Started
7 Jan 2026
Primary completion
30 Nov 2032
Arms
R2 substudy
Results
None posted
  1. 22 Dec 2025: Trial registered
  2. 7 Jan 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.